TVRD

Tvardi Therapeutics
TVRD

Overview Fund Trends Analyst Outlook Journalist POV

70 hedge funds and large institutions have $120M invested in Tvardi Therapeutics in 2016 Q2 according to their latest regulatory filings, with 9 funds opening new positions, 28 increasing their positions, 22 reducing their positions, and 32 closing their positions.

New
Increased
Maintained
Reduced
Closed

more repeat investments, than reductions

Existing positions increased: | Existing positions reduced:

more capital invested

Capital invested by funds: $ → $

more funds holding in top 10

Funds holding in top 10: →

less funds holding

Funds holding: →

66% less call options, than puts

Call options by funds: $26K | Put options by funds: $76K

72% less first-time investments, than exits

New positions opened: 9 | Existing positions closed: 32

Holders
70
Holders Change
Holders Change %
% of All Funds
Holding in Top 10
2
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
Increased
Reduced
Closed
Calls
$26K
Puts
$76K
Net Calls
Net Calls Change

Top Buyers

1
+$34.9M
2
+$4.26M
3
+$642K
4
BCM
Bridgeway Capital Management
Texas
+$350K
5
NPC
National Planning Corporation
California
+$332K

Top Sellers

1
-$9.9M
2
-$7.54M
3
-$4.11M
4
ARTA
A.R.T. Advisors
New York
-$866K
5
Wellington Management Group
Wellington Management Group
Massachusetts
-$559K
Name Holding Trade Value Shares
Change 		Change in
Stake
76
–
77
–
78
–
79
–
80
–
81
–
82
–
83
–
84
–
85
–
86
–
87
–
88
–
89
–
90
–
91
–
92
–
93
–
94
–
95
–
96
–
97
–
98
–
99
–
1 2 3
4